Posted
Video length: 1 min.
A treatment for Alzheimer’s disease has shown very promising results after a clinical study. A source of hope, but we must remain cautious. Explanations with the doctor and journalist Damien Mascret, present on the set of 12/13, Friday July 21.
“You have to be careful“, warns the doctor and journalist Damien Mascret, present on the set of 12/13, Friday July 21. “On the one hand, we understand the enthusiasm of neurologists, because they saw the amyloid plaques in the brain, markers of Alzheimer’s disease, which decreased by 88%. But on the other hand, the symptoms were finally slowed down very little in the patients, who still continued to worsen”he explains, specifying that only a few months on the evolution of the disease have been gained.
Risks
The treatment is also not without risk, since “it there were twice as many cerebral microhaemorrhages in the treated group”, as well as three deaths out of the 876 patients treated. Will the treatment soon be available in France? “Too early to say“, estimates the doctor. Indeed, the health authorities could not be satisfied with the decline of 18 months of the study. It is also necessary to pass the stage of the European Medicines Agency, then to wait for the opinion of the High authority of health to know if the drug deserves or not to be reimbursed.